Fabio Penna
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Chemotherapy induces tissue NAD + loss, and downregulation of NAD + biosynthetic enzyme Nrk2 marks muscle wasting.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Autophagy in cancer cachexia: From mechanisms to therapeutic opportunities.
Journal: International review of cell and molecular biology
Published: June 10, 2026
Mechanism-based nutritional approaches in cancer cachexia.
Journal: Current opinion in clinical nutrition and metabolic care
Published: January 07, 2026
Fasting-mimicking diet counteracts gut microbial dysbiosis in experimental lynch syndrome.
Journal: Cancer & metabolism
Published: December 02, 2025
Report of the XXI Meeting of the Interuniversity Institute of Myology and preview of the XXII edition.
Journal: European journal of translational myology
Published: February 17, 2025
BNIP3 Downregulation Ameliorates Muscle Atrophy in Cancer Cachexia.
Journal: Cancers
Published: November 08, 2024
Systemic metabolic crosstalk as driver of cancer cachexia.
Journal: Trends in endocrinology and metabolism: TEM
Published: September 25, 2024
Extracellular Vesicles and Exosomes in the Control of the Musculoskeletal Health.
Journal: Current osteoporosis reports
Published: February 21, 2024
Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging.
Journal: Molecular aspects of medicine
Published: February 02, 2024
Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting.
Journal: International journal of molecular sciences
Published: October 13, 2023
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity.
Journal: Journal of advanced research
Published: August 17, 2023
Last Updated: 09/26/2026